Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2011

View Archived Issues

Pfizer offers overview of second quarter 2011

Sanofi discovers new lysophospholipid S1P1 receptor agonists

Axin-2 as a key regulator of remyelination

MSX-1 missense substitution linked to familial hypodontia

New voltage-gated calcium channel blockers synthesized

Novel chalcone-linked imidazolone compounds disclosed by CSIR

Addex patents novel metabotropic glutamate mGlu4 receptor modulators

Theravance presents new norepinephrine/serotonin reuptake inhibitors

Palatin Technologies confirms commencement of phase I trial of AZD-2820

AAA obtains rights to anticancer antibody fragment from Dompe

CBio presents data from phase IIa XToll trial in rheumatoid arthritis

Repros Therapeutics reports data from Androxal study in men with type 2 diabetes

Victrelis obtains approval in Canada for chronic hepatitis C

Decitabine plus carboplatin shows promise in phase II ovarian cancer trial

MMRF and Onyx launch carfilzomib expanded access program

Trius Therapeutics reaches agreement with FDA for phase III torezolid trial

Chains of magnetasomes show antitumor effects in preclinical study

MolMed to develop production process for gene therapy for GSK

Alexza resubmits NDA to FDA for AZ-004

Axanum obtains positive agreement for E.U. approval

Genmab reports topline results for ofatumumab in aggressive lymphoma

FDA continues review of EUSA Pharma's BLA for Erwinaze in acute lymphoblastic leukemia

Amgen presents highlights of second quarter 2011

STATegics receives grant to advance product candidates for Friedreich's ataxia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...